摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

甲基8-甲基-3,4-二氢-2H-1,5-苯并二氧杂卓-6-羧酸酯 | 819800-56-1

中文名称
甲基8-甲基-3,4-二氢-2H-1,5-苯并二氧杂卓-6-羧酸酯
中文别名
——
英文名称
methyl 8-methyl-3,4-dihydro-2H-1,5-benzodioxepine-6-carboxylate
英文别名
——
甲基8-甲基-3,4-二氢-2H-1,5-苯并二氧杂卓-6-羧酸酯化学式
CAS
819800-56-1
化学式
C12H14O4
mdl
——
分子量
222.241
InChiKey
GVXDYTPYBCUZRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] AMINOSULFONYL SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES AS 5HT4-ANTAGONISTS<br/>[FR] AMINOSULFONYLE SUBSTITUE 4-(AMINOMETHYLE)-PIPERIDINE BENZAMIDES UTILISE COMME 5HT4-ANTAGONISTES
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2005000837A1
    公开(公告)日:2005-01-06
    The present invention is concerned with novel compounds of formula (I) having 5HT4-antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
    本发明涉及具有5HT4-拮抗性质的式(I)的新化合物。该发明还涉及制备这种新化合物的方法,包括这些新化合物的药物组合物以及这些化合物作为药物的用途。
  • [EN] HYDROXYCARBONYLPHENYL SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES AS 5HT4-ANTAGONISTS<br/>[FR] 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES SUBSTITUES PAR HYDROXYCARBONYLPHENYLE, UTILISES COMME ANTAGONISTES DES RECEPTEURS 5HT4
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2005003121A1
    公开(公告)日:2005-01-13
    The present invention is concerned with novel compounds of formula (I) having 5HT4-antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
    本发明涉及具有5HT4拮抗性质的式(I)的新化合物。该发明还涉及制备这种新化合物的方法,包括该新化合物的药物组合物以及该化合物的药用。
  • Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
    申请人:Bosmans René Marie André Jean-Paul
    公开号:US20070197600A1
    公开(公告)日:2007-08-23
    The present invention is concerned with novel compounds of formula (I) having 5HT 4 -antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
    本发明涉及具有5HT4拮抗性质的化合物(I)的新颖化合物。本发明还涉及制备这种新颖化合物的方法,含有该新颖化合物的药物组合物以及该化合物作为药物的使用。
  • Aminosulfonyl Substituted 4-(Aminomethyl)-Piperidine Benzamides As 5HT 4-Antagonists
    申请人:BOSMANS Jean-Paul René Marie André
    公开号:US20100087483A1
    公开(公告)日:2010-04-08
    The present invention is concerned with novel compounds of formula (I) having 5HT 4 -antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
    本发明涉及具有5HT4-拮抗性质的式(I)新化合物。本发明还涉及制备这种新化合物的方法,包含这种新化合物的药物组合物以及这种化合物作为药物的用途。
  • HIV REPLICATION INHIBITOR
    申请人:Shionogi & Co., Ltd.
    公开号:EP2772480A1
    公开(公告)日:2014-09-03
    The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. wherein, a broken line means the presence or absence of a bond; R1 is substituted or unsubstituted alkyl etc., R2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R3 is a substituted or unsubstituted aromatic carbocyclic group; R4 is a hydrogen atom etc.; R5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R6 is substituted or unsubstituted alkyl; R7 is -Z-R71 etc.; Z is - NR72-CO- etc.; R71 is substituted or unsubstituted alkyl etc.; R72 is a hydrogen atom etc.
    本发明提供了一种具有抗病毒作用,特别是抑制艾滋病毒复制作用的新型化合物,以及一种药物组合物,特别是一种抗艾滋病毒制剂。 其中,断线表示存在或不存在键;R1 是取代或未取代的烷基等、R2 是取代或未取代的烷氧基等;n 是 1 或 2;R3 是取代或未取代的芳香族碳环基团;R4 是氢原子等;R5 是取代或未取代的芳香族碳环基团等;Y 是单键等;R6 是取代或未取代的烷基;R7 是-Z-R71 等;Z 是-NR72-CO- 等;R71 是取代或未取代的烷基等;R72 是氢原子等。
查看更多